141 related articles for article (PubMed ID: 29029833)
1. Interim
Cremonesi M; Garibaldi C; Timmerman R; Ferrari M; Ronchi S; Grana CM; Travaini L; Gilardi L; Starzyńska A; Ciardo D; Orecchia R; Jereczek-Fossa BA; Leonardi MC
Radiother Oncol; 2017 Nov; 125(2):200-212. PubMed ID: 29029833
[TBL] [Abstract][Full Text] [Related]
2. Role of interim
Cremonesi M; Gilardi L; Ferrari ME; Piperno G; Travaini LL; Timmerman R; Botta F; Baroni G; Grana CM; Ronchi S; Ciardo D; Jereczek-Fossa BA; Garibaldi C; Orecchia R
Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1915-1927. PubMed ID: 28681192
[TBL] [Abstract][Full Text] [Related]
3. High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer.
Calais J; Dubray B; Nkhali L; Thureau S; Lemarignier C; Modzelewski R; Gardin I; Di Fiore F; Michel P; Vera P
Eur J Nucl Med Mol Imaging; 2015 May; 42(6):858-67. PubMed ID: 25680400
[TBL] [Abstract][Full Text] [Related]
4. Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy.
Kim MK; Ryu JS; Kim SB; Ahn JH; Kim SY; Park SI; Kim YH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH
Eur J Cancer; 2007 Jun; 43(9):1385-91. PubMed ID: 17512192
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of
Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
[TBL] [Abstract][Full Text] [Related]
6. Ineffectiveness of ¹⁸F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer.
Piessen G; Petyt G; Duhamel A; Mirabel X; Huglo D; Mariette C
Ann Surg; 2013 Jul; 258(1):66-76. PubMed ID: 23470576
[TBL] [Abstract][Full Text] [Related]
7. Interim
Garibaldi C; Ronchi S; Cremonesi M; Gilardi L; Travaini L; Ferrari M; Alterio D; Kaanders JHAM; Ciardo D; Orecchia R; Jereczek-Fossa BA; Grana CM
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):555-573. PubMed ID: 28581396
[TBL] [Abstract][Full Text] [Related]
8. Early metabolic response to chemoradiotherapy by interim FDG PET/CT is associated with better overall survival and histological response in esophageal cancers.
Hammoudi N; Hennequin C; Vercellino L; Costantini A; Valverde A; Cattan P; Quéro L
Dig Liver Dis; 2019 Jun; 51(6):887-893. PubMed ID: 30630738
[TBL] [Abstract][Full Text] [Related]
9. Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment
Beukinga RJ; Hulshoff JB; van Dijk LV; Muijs CT; Burgerhof JGM; Kats-Ugurlu G; Slart RHJA; Slump CH; Mul VEM; Plukker JTM
J Nucl Med; 2017 May; 58(5):723-729. PubMed ID: 27738011
[TBL] [Abstract][Full Text] [Related]
10. Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring.
Minamimoto R; Fayad L; Advani R; Vose J; Macapinlac H; Meza J; Hankins J; Mottaghy F; Juweid M; Quon A
Radiology; 2016 Jul; 280(1):220-9. PubMed ID: 26854705
[TBL] [Abstract][Full Text] [Related]
11. Distribution of lymph node metastases on FDG-PET/CT in inoperable or unresectable oesophageal cancer patients and the impact on target volume definition in radiation therapy.
Machiels M; Wouterse SJ; Geijsen ED; van Os RM; Bennink RJ; van Laarhoven HW; Hulshof MC
J Med Imaging Radiat Oncol; 2016 Aug; 60(4):520-7. PubMed ID: 27197751
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer.
Levine EA; Farmer MR; Clark P; Mishra G; Ho C; Geisinger KR; Melin SA; Lovato J; Oaks T; Blackstock AW
Ann Surg; 2006 Apr; 243(4):472-8. PubMed ID: 16552197
[TBL] [Abstract][Full Text] [Related]
13. Role of
Sasaki K; Uchikado Y; Okumura H; Omoto I; Kita Y; Arigami T; Uenosono Y; Owaki T; Maemura K; Natsugoe S
Anticancer Res; 2017 Feb; 37(2):859-864. PubMed ID: 28179343
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of metabolic response measured by 18F-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy.
Onal C; Torun N; Guler OC; Yildirim BA
Nucl Med Commun; 2016 Dec; 37(12):1282-1289. PubMed ID: 27612030
[TBL] [Abstract][Full Text] [Related]
15. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
Katsoulis IE; Wong WL; Mattheou AK; Damani N; Chambers J; Livingstone JI
Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
[TBL] [Abstract][Full Text] [Related]
16. Correlation between fluorodeoxyglucose hotspots on preradiotherapy PET/CT and areas of cancer local relapse: Systematic review of literature.
Abgral R; Bourhis D; Calais J; Lucia F; Leclère JC; Salaün PY; Vera P; Schick U
Cancer Radiother; 2020 Aug; 24(5):444-452. PubMed ID: 32620457
[TBL] [Abstract][Full Text] [Related]
17. (18)F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer.
Jingu K; Kaneta T; Nemoto K; Takeda K; Ogawa Y; Ariga H; Koto M; Sakayauchi T; Takai Y; Takahashi S; Yamada S
Int J Clin Oncol; 2010 Apr; 15(2):184-90. PubMed ID: 20217449
[TBL] [Abstract][Full Text] [Related]
18. Can ¹⁸F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis.
Chen YM; Pan XF; Tong LJ; Shi YP; Chen T
Nucl Med Commun; 2011 Nov; 32(11):1005-10. PubMed ID: 21886014
[TBL] [Abstract][Full Text] [Related]
19. Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response.
Gerbaudo VH; Killoran JH; Kim CK; Hornick JL; Nowak JA; Enzinger PC; Mamon HJ
Ann Nucl Med; 2018 Apr; 32(3):165-174. PubMed ID: 29332233
[TBL] [Abstract][Full Text] [Related]
20. Radiation-induced liver injury mimicking liver metastases on FDG-PET-CT after chemoradiotherapy for esophageal cancer : A retrospective study and literature review.
Voncken FEM; Aleman BMP; van Dieren JM; Grootscholten C; Lalezari F; van Sandick JW; Steinberg JD; Vegt E
Strahlenther Onkol; 2018 Feb; 194(2):156-163. PubMed ID: 29051991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
